pubmed-article:19997959 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:19997959 | lifeskim:mentions | umls-concept:C0006826 | lld:lifeskim |
pubmed-article:19997959 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:19997959 | lifeskim:mentions | umls-concept:C0013089 | lld:lifeskim |
pubmed-article:19997959 | lifeskim:mentions | umls-concept:C0964264 | lld:lifeskim |
pubmed-article:19997959 | lifeskim:mentions | umls-concept:C0920321 | lld:lifeskim |
pubmed-article:19997959 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
pubmed-article:19997959 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:19997959 | pubmed:dateCreated | 2011-2-11 | lld:pubmed |
pubmed-article:19997959 | pubmed:abstractText | To assess the safety, maximum-tolerated dose (MTD), and dose-limiting toxicities (DLT), of motexafin gadolinium (MGd), given in combination with doxorubicin, in patients with advanced solid tumors. | lld:pubmed |
pubmed-article:19997959 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19997959 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19997959 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19997959 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19997959 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19997959 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19997959 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19997959 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19997959 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19997959 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19997959 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19997959 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19997959 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19997959 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19997959 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19997959 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19997959 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19997959 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19997959 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19997959 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19997959 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19997959 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19997959 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19997959 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19997959 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19997959 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19997959 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19997959 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19997959 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19997959 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19997959 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19997959 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19997959 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19997959 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19997959 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19997959 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19997959 | pubmed:language | eng | lld:pubmed |
pubmed-article:19997959 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19997959 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:19997959 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19997959 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19997959 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19997959 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19997959 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:19997959 | pubmed:month | Apr | lld:pubmed |
pubmed-article:19997959 | pubmed:issn | 1573-0646 | lld:pubmed |
pubmed-article:19997959 | pubmed:author | pubmed-author:RamanathanRam... | lld:pubmed |
pubmed-article:19997959 | pubmed:author | pubmed-author:AlbertiDonaD | lld:pubmed |
pubmed-article:19997959 | pubmed:author | pubmed-author:WildingGeorge... | lld:pubmed |
pubmed-article:19997959 | pubmed:author | pubmed-author:BaileyHoward... | lld:pubmed |
pubmed-article:19997959 | pubmed:author | pubmed-author:ModyTarak DTD | lld:pubmed |
pubmed-article:19997959 | pubmed:author | pubmed-author:ThomasJames... | lld:pubmed |
pubmed-article:19997959 | pubmed:author | pubmed-author:TraynorAnne... | lld:pubmed |
pubmed-article:19997959 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:19997959 | pubmed:volume | 29 | lld:pubmed |
pubmed-article:19997959 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:19997959 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:19997959 | pubmed:pagination | 316-22 | lld:pubmed |
pubmed-article:19997959 | pubmed:dateRevised | 2011-7-27 | lld:pubmed |
pubmed-article:19997959 | pubmed:meshHeading | pubmed-meshheading:19997959... | lld:pubmed |
pubmed-article:19997959 | pubmed:meshHeading | pubmed-meshheading:19997959... | lld:pubmed |
pubmed-article:19997959 | pubmed:meshHeading | pubmed-meshheading:19997959... | lld:pubmed |
pubmed-article:19997959 | pubmed:meshHeading | pubmed-meshheading:19997959... | lld:pubmed |
pubmed-article:19997959 | pubmed:meshHeading | pubmed-meshheading:19997959... | lld:pubmed |
pubmed-article:19997959 | pubmed:meshHeading | pubmed-meshheading:19997959... | lld:pubmed |
pubmed-article:19997959 | pubmed:meshHeading | pubmed-meshheading:19997959... | lld:pubmed |
pubmed-article:19997959 | pubmed:meshHeading | pubmed-meshheading:19997959... | lld:pubmed |
pubmed-article:19997959 | pubmed:meshHeading | pubmed-meshheading:19997959... | lld:pubmed |
pubmed-article:19997959 | pubmed:meshHeading | pubmed-meshheading:19997959... | lld:pubmed |
pubmed-article:19997959 | pubmed:meshHeading | pubmed-meshheading:19997959... | lld:pubmed |
pubmed-article:19997959 | pubmed:meshHeading | pubmed-meshheading:19997959... | lld:pubmed |
pubmed-article:19997959 | pubmed:meshHeading | pubmed-meshheading:19997959... | lld:pubmed |
pubmed-article:19997959 | pubmed:meshHeading | pubmed-meshheading:19997959... | lld:pubmed |
pubmed-article:19997959 | pubmed:year | 2011 | lld:pubmed |
pubmed-article:19997959 | pubmed:articleTitle | Phase I trial of motexafin gadolinium and doxorubicin in the treatment of advanced malignancies. | lld:pubmed |
pubmed-article:19997959 | pubmed:affiliation | University of Wisconsin Paul P. Carbone Comprehensive Cancer Center, Madison, WI 53792, USA. amt@medicine.wisc.edu | lld:pubmed |
pubmed-article:19997959 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:19997959 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:19997959 | pubmed:publicationType | Multicenter Study | lld:pubmed |
pubmed-article:19997959 | pubmed:publicationType | Clinical Trial, Phase I | lld:pubmed |